nodes	percent_of_prediction	percent_of_DWPC	metapath
Paricalcitol—CYP3A4—Topotecan—ovarian cancer	0.0291	0.354	CbGbCtD
Paricalcitol—CYP3A4—Vinorelbine—ovarian cancer	0.0205	0.249	CbGbCtD
Paricalcitol—CYP3A4—Paclitaxel—ovarian cancer	0.0144	0.175	CbGbCtD
Paricalcitol—VDR—Ovarian Infertility Genes—NR5A1—ovarian cancer	0.0108	0.0525	CbGpPWpGaD
Paricalcitol—VDR—Ovarian Infertility Genes—INHA—ovarian cancer	0.0105	0.0511	CbGpPWpGaD
Paricalcitol—CYP3A4—Docetaxel—ovarian cancer	0.0104	0.127	CbGbCtD
Paricalcitol—VDR—Nuclear Receptors—NR5A1—ovarian cancer	0.00939	0.0458	CbGpPWpGaD
Paricalcitol—CYP24A1—endometrium—ovarian cancer	0.00842	0.135	CbGeAlD
Paricalcitol—CYP3A4—Doxorubicin—ovarian cancer	0.00776	0.0945	CbGbCtD
Paricalcitol—VDR—Nuclear Receptor transcription pathway—NR5A1—ovarian cancer	0.00742	0.0362	CbGpPWpGaD
Paricalcitol—CYP24A1—female reproductive system—ovarian cancer	0.00698	0.112	CbGeAlD
Paricalcitol—CYP24A1—vagina—ovarian cancer	0.00631	0.101	CbGeAlD
Paricalcitol—VDR—Drug Induction of Bile Acid Pathway—ABCB1—ovarian cancer	0.00623	0.0304	CbGpPWpGaD
Paricalcitol—UGT1A4—Tamoxifen metabolism—CYP1B1—ovarian cancer	0.00609	0.0297	CbGpPWpGaD
Paricalcitol—VDR—Ovarian Infertility Genes—MLH1—ovarian cancer	0.00566	0.0276	CbGpPWpGaD
Paricalcitol—VDR—Validated transcriptional targets of deltaNp63 isoforms—TP63—ovarian cancer	0.00549	0.0268	CbGpPWpGaD
Paricalcitol—VDR—Ovarian Infertility Genes—PGR—ovarian cancer	0.00536	0.0262	CbGpPWpGaD
Paricalcitol—VDR—epithelium—ovarian cancer	0.00517	0.0831	CbGeAlD
Paricalcitol—VDR—uterine cervix—ovarian cancer	0.00513	0.0824	CbGeAlD
Paricalcitol—VDR—Validated transcriptional targets of TAp63 isoforms—TP63—ovarian cancer	0.00491	0.024	CbGpPWpGaD
Paricalcitol—VDR—decidua—ovarian cancer	0.00488	0.0785	CbGeAlD
Paricalcitol—VDR—Nuclear Receptors—PGR—ovarian cancer	0.00467	0.0228	CbGpPWpGaD
Paricalcitol—VDR—Validated transcriptional targets of deltaNp63 isoforms—YAP1—ovarian cancer	0.00452	0.022	CbGpPWpGaD
Paricalcitol—VDR—Ovarian Infertility Genes—CCND2—ovarian cancer	0.00429	0.0209	CbGpPWpGaD
Paricalcitol—VDR—uterus—ovarian cancer	0.00427	0.0687	CbGeAlD
Paricalcitol—CYP24A1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ovarian cancer	0.00427	0.0208	CbGpPWpGaD
Paricalcitol—VDR—Direct p53 effectors—CD82—ovarian cancer	0.00395	0.0192	CbGpPWpGaD
Paricalcitol—VDR—female reproductive system—ovarian cancer	0.00384	0.0617	CbGeAlD
Paricalcitol—VDR—Nuclear Receptor transcription pathway—PGR—ovarian cancer	0.00369	0.018	CbGpPWpGaD
Paricalcitol—VDR—Validated transcriptional targets of deltaNp63 isoforms—FASN—ovarian cancer	0.00368	0.018	CbGpPWpGaD
Paricalcitol—VDR—bone marrow—ovarian cancer	0.00363	0.0583	CbGeAlD
Paricalcitol—UGT1A4—Constitutive Androstane Receptor Pathway—ABCB1—ovarian cancer	0.00358	0.0175	CbGpPWpGaD
Paricalcitol—VDR—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ovarian cancer	0.00358	0.0174	CbGpPWpGaD
Paricalcitol—VDR—female gonad—ovarian cancer	0.00349	0.0562	CbGeAlD
Paricalcitol—VDR—vagina—ovarian cancer	0.00347	0.0558	CbGeAlD
Paricalcitol—VDR—Validated transcriptional targets of TAp63 isoforms—GADD45A—ovarian cancer	0.00329	0.0161	CbGpPWpGaD
Paricalcitol—CYP24A1—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	0.00329	0.0161	CbGpPWpGaD
Paricalcitol—UGT1A4—Aryl Hydrocarbon Receptor Pathway—CYP1B1—ovarian cancer	0.00325	0.0159	CbGpPWpGaD
Paricalcitol—CYP24A1—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	0.00325	0.0158	CbGpPWpGaD
Paricalcitol—VDR—testis—ovarian cancer	0.0031	0.0498	CbGeAlD
Paricalcitol—VDR—Regulation of nuclear SMAD2/3 signaling—ATF3—ovarian cancer	0.00296	0.0145	CbGpPWpGaD
Paricalcitol—VDR—Validated transcriptional targets of deltaNp63 isoforms—BRCA2—ovarian cancer	0.00285	0.0139	CbGpPWpGaD
Paricalcitol—CYP24A1—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.00267	0.013	CbGpPWpGaD
Paricalcitol—VDR—Nuclear Receptors—ESR1—ovarian cancer	0.0025	0.0122	CbGpPWpGaD
Paricalcitol—VDR—Direct p53 effectors—TP63—ovarian cancer	0.00229	0.0112	CbGpPWpGaD
Paricalcitol—VDR—lymph node—ovarian cancer	0.00225	0.0361	CbGeAlD
Paricalcitol—VDR—Nuclear Receptor transcription pathway—ESR1—ovarian cancer	0.00197	0.00962	CbGpPWpGaD
Paricalcitol—CYP3A4—Liver X Receptor Pathway—FASN—ovarian cancer	0.00197	0.00959	CbGpPWpGaD
Paricalcitol—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—ovarian cancer	0.00195	0.0095	CbGpPWpGaD
Paricalcitol—VDR—Ovarian Infertility Genes—CDKN1B—ovarian cancer	0.00195	0.00949	CbGpPWpGaD
Paricalcitol—VDR—Direct p53 effectors—MSH2—ovarian cancer	0.00193	0.0094	CbGpPWpGaD
Paricalcitol—VDR—Direct p53 effectors—ATF3—ovarian cancer	0.00191	0.00933	CbGpPWpGaD
Paricalcitol—VDR—Direct p53 effectors—SMARCA4—ovarian cancer	0.0018	0.00878	CbGpPWpGaD
Paricalcitol—CYP3A4—Codeine and Morphine Metabolism—ABCB1—ovarian cancer	0.00176	0.0086	CbGpPWpGaD
Paricalcitol—VDR—Direct p53 effectors—MLH1—ovarian cancer	0.00174	0.00847	CbGpPWpGaD
Paricalcitol—VDR—Retinoic acid receptors-mediated signaling—MAPK3—ovarian cancer	0.00161	0.00787	CbGpPWpGaD
Paricalcitol—VDR—Direct p53 effectors—GADD45A—ovarian cancer	0.00154	0.0075	CbGpPWpGaD
Paricalcitol—VDR—Retinoic acid receptors-mediated signaling—MAPK1—ovarian cancer	0.00153	0.00748	CbGpPWpGaD
Paricalcitol—CYP24A1—Biological oxidations—CYP1B1—ovarian cancer	0.00142	0.00691	CbGpPWpGaD
Paricalcitol—CYP24A1—Metapathway biotransformation—CYP1B1—ovarian cancer	0.0014	0.00682	CbGpPWpGaD
Paricalcitol—UGT1A4—NRF2 pathway—SLC5A5—ovarian cancer	0.00139	0.0068	CbGpPWpGaD
Paricalcitol—UGT1A4—Aryl Hydrocarbon Receptor Pathway—CDKN1B—ovarian cancer	0.00139	0.00677	CbGpPWpGaD
Paricalcitol—VDR—Regulation of nuclear SMAD2/3 signaling—ESR1—ovarian cancer	0.00136	0.00664	CbGpPWpGaD
Paricalcitol—UGT1A4—Aryl Hydrocarbon Receptor Pathway—IL2—ovarian cancer	0.00136	0.00663	CbGpPWpGaD
Paricalcitol—UGT1A4—NRF2 pathway—SLC2A1—ovarian cancer	0.00135	0.00657	CbGpPWpGaD
Paricalcitol—CYP3A4—female reproductive system—ovarian cancer	0.00128	0.0206	CbGeAlD
Paricalcitol—VDR—Generic Transcription Pathway—NR5A1—ovarian cancer	0.00128	0.00625	CbGpPWpGaD
Paricalcitol—UGT1A4—Biological oxidations—CYP1B1—ovarian cancer	0.00113	0.00553	CbGpPWpGaD
Paricalcitol—CYP3A4—Estrogen metabolism—CYP1B1—ovarian cancer	0.00112	0.00546	CbGpPWpGaD
Paricalcitol—UGT1A4—Metapathway biotransformation—CYP1B1—ovarian cancer	0.00112	0.00545	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	0.00109	0.00533	CbGpPWpGaD
Paricalcitol—VDR—Retinoic acid receptors-mediated signaling—AKT1—ovarian cancer	0.00109	0.0053	CbGpPWpGaD
Paricalcitol—UGT1A4—Aryl Hydrocarbon Receptor Pathway—EGFR—ovarian cancer	0.00104	0.00507	CbGpPWpGaD
Paricalcitol—CYP3A4—Tamoxifen metabolism—CYP1B1—ovarian cancer	0.000989	0.00482	CbGpPWpGaD
Paricalcitol—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—ovarian cancer	0.000965	0.0047	CbGpPWpGaD
Paricalcitol—VDR—Direct p53 effectors—CAV1—ovarian cancer	0.000912	0.00445	CbGpPWpGaD
Paricalcitol—VDR—Direct p53 effectors—MET—ovarian cancer	0.000883	0.00431	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—WDR77—ovarian cancer	0.000866	0.00422	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—NME2—ovarian cancer	0.000864	0.00421	CbGpPWpGaD
Paricalcitol—VDR—Direct p53 effectors—APC—ovarian cancer	0.000831	0.00405	CbGpPWpGaD
Paricalcitol—CYP3A4—Irinotecan Pathway—APC—ovarian cancer	0.000812	0.00396	CbGpPWpGaD
Paricalcitol—VDR—Direct p53 effectors—MMP2—ovarian cancer	0.000737	0.00359	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	0.000733	0.00357	CbGpPWpGaD
Paricalcitol—VDR—Generic Transcription Pathway—YAP1—ovarian cancer	0.000731	0.00356	CbGpPWpGaD
Paricalcitol—VDR—Regulation of nuclear SMAD2/3 signaling—MYC—ovarian cancer	0.000709	0.00346	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—NME2—ovarian cancer	0.000691	0.00337	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—TTF1—ovarian cancer	0.000679	0.00331	CbGpPWpGaD
Paricalcitol—VDR—Generic Transcription Pathway—PGR—ovarian cancer	0.000638	0.00311	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—NR5A1—ovarian cancer	0.000617	0.00301	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	0.000597	0.00291	CbGpPWpGaD
Paricalcitol—VDR—Generic Transcription Pathway—PARP1—ovarian cancer	0.000593	0.00289	CbGpPWpGaD
Paricalcitol—Anorexia—Paclitaxel—ovarian cancer	0.000591	0.000908	CcSEcCtD
Paricalcitol—Gastritis—Doxorubicin—ovarian cancer	0.00059	0.000907	CcSEcCtD
Paricalcitol—Vomiting—Vinorelbine—ovarian cancer	0.000586	0.0009	CcSEcCtD
Paricalcitol—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—ovarian cancer	0.000582	0.00284	CbGpPWpGaD
Paricalcitol—Rash—Vinorelbine—ovarian cancer	0.000581	0.000893	CcSEcCtD
Paricalcitol—Dermatitis—Vinorelbine—ovarian cancer	0.00058	0.000892	CcSEcCtD
Paricalcitol—Hypotension—Paclitaxel—ovarian cancer	0.000579	0.00089	CcSEcCtD
Paricalcitol—Upper respiratory tract infection—Epirubicin—ovarian cancer	0.000579	0.00089	CcSEcCtD
Paricalcitol—Headache—Vinorelbine—ovarian cancer	0.000577	0.000887	CcSEcCtD
Paricalcitol—Syncope—Docetaxel—ovarian cancer	0.000577	0.000887	CcSEcCtD
Paricalcitol—Dysphagia—Doxorubicin—ovarian cancer	0.000576	0.000886	CcSEcCtD
Paricalcitol—Influenza—Doxorubicin—ovarian cancer	0.000576	0.000886	CcSEcCtD
Paricalcitol—Asthma—Doxorubicin—ovarian cancer	0.000576	0.000886	CcSEcCtD
Paricalcitol—Leukopenia—Docetaxel—ovarian cancer	0.000576	0.000885	CcSEcCtD
Paricalcitol—Palpitations—Docetaxel—ovarian cancer	0.000569	0.000874	CcSEcCtD
Paricalcitol—Loss of consciousness—Docetaxel—ovarian cancer	0.000566	0.000869	CcSEcCtD
Paricalcitol—Pancreatitis—Doxorubicin—ovarian cancer	0.000565	0.000869	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000565	0.000868	CcSEcCtD
Paricalcitol—Weight decreased—Epirubicin—ovarian cancer	0.000564	0.000866	CcSEcCtD
Paricalcitol—Cough—Docetaxel—ovarian cancer	0.000562	0.000863	CcSEcCtD
Paricalcitol—Insomnia—Paclitaxel—ovarian cancer	0.00056	0.000861	CcSEcCtD
Paricalcitol—Pneumonia—Epirubicin—ovarian cancer	0.000559	0.000859	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—CYTB—ovarian cancer	0.000557	0.00272	CbGpPWpGaD
Paricalcitol—Paraesthesia—Paclitaxel—ovarian cancer	0.000556	0.000855	CcSEcCtD
Paricalcitol—Hypertension—Docetaxel—ovarian cancer	0.000556	0.000854	CcSEcCtD
Paricalcitol—Infestation—Epirubicin—ovarian cancer	0.000555	0.000854	CcSEcCtD
Paricalcitol—Infestation NOS—Epirubicin—ovarian cancer	0.000555	0.000854	CcSEcCtD
Paricalcitol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ovarian cancer	0.000554	0.0027	CbGpPWpGaD
Paricalcitol—Dyspnoea—Paclitaxel—ovarian cancer	0.000552	0.000849	CcSEcCtD
Paricalcitol—Somnolence—Paclitaxel—ovarian cancer	0.000551	0.000847	CcSEcCtD
Paricalcitol—VDR—Direct p53 effectors—PTEN—ovarian cancer	0.00055	0.00268	CbGpPWpGaD
Paricalcitol—Chest pain—Docetaxel—ovarian cancer	0.000548	0.000842	CcSEcCtD
Paricalcitol—Arthralgia—Docetaxel—ovarian cancer	0.000548	0.000842	CcSEcCtD
Paricalcitol—Myalgia—Docetaxel—ovarian cancer	0.000548	0.000842	CcSEcCtD
Paricalcitol—Nausea—Vinorelbine—ovarian cancer	0.000547	0.000841	CcSEcCtD
Paricalcitol—Dyspepsia—Paclitaxel—ovarian cancer	0.000545	0.000838	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	0.000544	0.00265	CbGpPWpGaD
Paricalcitol—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000544	0.000836	CcSEcCtD
Paricalcitol—Urinary tract infection—Epirubicin—ovarian cancer	0.00054	0.00083	CcSEcCtD
Paricalcitol—Conjunctivitis—Epirubicin—ovarian cancer	0.00054	0.00083	CcSEcCtD
Paricalcitol—Decreased appetite—Paclitaxel—ovarian cancer	0.000539	0.000828	CcSEcCtD
Paricalcitol—Dry mouth—Docetaxel—ovarian cancer	0.000536	0.000824	CcSEcCtD
Paricalcitol—Upper respiratory tract infection—Doxorubicin—ovarian cancer	0.000536	0.000823	CcSEcCtD
Paricalcitol—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000535	0.000822	CcSEcCtD
Paricalcitol—Fatigue—Paclitaxel—ovarian cancer	0.000534	0.000821	CcSEcCtD
Paricalcitol—Sweating—Epirubicin—ovarian cancer	0.000532	0.000818	CcSEcCtD
Paricalcitol—Pain—Paclitaxel—ovarian cancer	0.00053	0.000814	CcSEcCtD
Paricalcitol—Constipation—Paclitaxel—ovarian cancer	0.00053	0.000814	CcSEcCtD
Paricalcitol—Confusional state—Docetaxel—ovarian cancer	0.00053	0.000814	CcSEcCtD
Paricalcitol—CYP3A4—Tryptophan metabolism—CYP1B1—ovarian cancer	0.000528	0.00258	CbGpPWpGaD
Paricalcitol—Oedema—Docetaxel—ovarian cancer	0.000525	0.000807	CcSEcCtD
Paricalcitol—Epistaxis—Epirubicin—ovarian cancer	0.000524	0.000805	CcSEcCtD
Paricalcitol—Infection—Docetaxel—ovarian cancer	0.000522	0.000802	CcSEcCtD
Paricalcitol—Weight decreased—Doxorubicin—ovarian cancer	0.000521	0.000802	CcSEcCtD
Paricalcitol—Sinusitis—Epirubicin—ovarian cancer	0.000521	0.000801	CcSEcCtD
Paricalcitol—Pneumonia—Doxorubicin—ovarian cancer	0.000517	0.000795	CcSEcCtD
Paricalcitol—Shock—Docetaxel—ovarian cancer	0.000517	0.000794	CcSEcCtD
Paricalcitol—Nervous system disorder—Docetaxel—ovarian cancer	0.000515	0.000792	CcSEcCtD
Paricalcitol—Infestation—Doxorubicin—ovarian cancer	0.000514	0.00079	CcSEcCtD
Paricalcitol—Infestation NOS—Doxorubicin—ovarian cancer	0.000514	0.00079	CcSEcCtD
Paricalcitol—Feeling abnormal—Paclitaxel—ovarian cancer	0.000511	0.000785	CcSEcCtD
Paricalcitol—Skin disorder—Docetaxel—ovarian cancer	0.00051	0.000784	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000507	0.000779	CcSEcCtD
Paricalcitol—Anorexia—Docetaxel—ovarian cancer	0.000501	0.00077	CcSEcCtD
Paricalcitol—Urinary tract infection—Doxorubicin—ovarian cancer	0.0005	0.000768	CcSEcCtD
Paricalcitol—Conjunctivitis—Doxorubicin—ovarian cancer	0.0005	0.000768	CcSEcCtD
Paricalcitol—Hypoaesthesia—Epirubicin—ovarian cancer	0.000496	0.000763	CcSEcCtD
Paricalcitol—Pharyngitis—Epirubicin—ovarian cancer	0.000495	0.000761	CcSEcCtD
Paricalcitol—Sweating—Doxorubicin—ovarian cancer	0.000493	0.000757	CcSEcCtD
Paricalcitol—Urinary tract disorder—Epirubicin—ovarian cancer	0.000492	0.000757	CcSEcCtD
Paricalcitol—Urticaria—Paclitaxel—ovarian cancer	0.000492	0.000757	CcSEcCtD
Paricalcitol—VDR—Regulation of nuclear SMAD2/3 signaling—AKT1—ovarian cancer	0.000491	0.0024	CbGpPWpGaD
Paricalcitol—Oedema peripheral—Epirubicin—ovarian cancer	0.000491	0.000755	CcSEcCtD
Paricalcitol—Hypotension—Docetaxel—ovarian cancer	0.000491	0.000754	CcSEcCtD
Paricalcitol—Connective tissue disorder—Epirubicin—ovarian cancer	0.00049	0.000753	CcSEcCtD
Paricalcitol—Abdominal pain—Paclitaxel—ovarian cancer	0.00049	0.000753	CcSEcCtD
Paricalcitol—Body temperature increased—Paclitaxel—ovarian cancer	0.00049	0.000753	CcSEcCtD
Paricalcitol—Urethral disorder—Epirubicin—ovarian cancer	0.000489	0.000751	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—PPP1CC—ovarian cancer	0.000487	0.00237	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—BRIP1—ovarian cancer	0.000487	0.00237	CbGpPWpGaD
Paricalcitol—Epistaxis—Doxorubicin—ovarian cancer	0.000485	0.000745	CcSEcCtD
Paricalcitol—Sinusitis—Doxorubicin—ovarian cancer	0.000482	0.000741	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000478	0.000736	CcSEcCtD
Paricalcitol—Insomnia—Docetaxel—ovarian cancer	0.000475	0.00073	CcSEcCtD
Paricalcitol—Paraesthesia—Docetaxel—ovarian cancer	0.000472	0.000725	CcSEcCtD
Paricalcitol—Dyspnoea—Docetaxel—ovarian cancer	0.000468	0.00072	CcSEcCtD
Paricalcitol—Somnolence—Docetaxel—ovarian cancer	0.000467	0.000718	CcSEcCtD
Paricalcitol—Eye disorder—Epirubicin—ovarian cancer	0.000466	0.000716	CcSEcCtD
Paricalcitol—Cardiac disorder—Epirubicin—ovarian cancer	0.000463	0.000711	CcSEcCtD
Paricalcitol—Dyspepsia—Docetaxel—ovarian cancer	0.000462	0.000711	CcSEcCtD
Paricalcitol—Hypoaesthesia—Doxorubicin—ovarian cancer	0.000459	0.000706	CcSEcCtD
Paricalcitol—Pharyngitis—Doxorubicin—ovarian cancer	0.000458	0.000704	CcSEcCtD
Paricalcitol—Decreased appetite—Docetaxel—ovarian cancer	0.000457	0.000702	CcSEcCtD
Paricalcitol—Hypersensitivity—Paclitaxel—ovarian cancer	0.000457	0.000702	CcSEcCtD
Paricalcitol—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000456	0.0007	CcSEcCtD
Paricalcitol—Oedema peripheral—Doxorubicin—ovarian cancer	0.000454	0.000699	CcSEcCtD
Paricalcitol—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000453	0.000697	CcSEcCtD
Paricalcitol—Connective tissue disorder—Doxorubicin—ovarian cancer	0.000453	0.000697	CcSEcCtD
Paricalcitol—Fatigue—Docetaxel—ovarian cancer	0.000453	0.000696	CcSEcCtD
Paricalcitol—Angiopathy—Epirubicin—ovarian cancer	0.000452	0.000695	CcSEcCtD
Paricalcitol—Urethral disorder—Doxorubicin—ovarian cancer	0.000452	0.000695	CcSEcCtD
Paricalcitol—Immune system disorder—Epirubicin—ovarian cancer	0.00045	0.000692	CcSEcCtD
Paricalcitol—Mediastinal disorder—Epirubicin—ovarian cancer	0.000449	0.000691	CcSEcCtD
Paricalcitol—Pain—Docetaxel—ovarian cancer	0.000449	0.00069	CcSEcCtD
Paricalcitol—Constipation—Docetaxel—ovarian cancer	0.000449	0.00069	CcSEcCtD
Paricalcitol—Chills—Epirubicin—ovarian cancer	0.000447	0.000688	CcSEcCtD
Paricalcitol—VDR—Direct p53 effectors—EGFR—ovarian cancer	0.000447	0.00218	CbGpPWpGaD
Paricalcitol—Arrhythmia—Epirubicin—ovarian cancer	0.000445	0.000685	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—CYTB—ovarian cancer	0.000445	0.00217	CbGpPWpGaD
Paricalcitol—Asthenia—Paclitaxel—ovarian cancer	0.000445	0.000683	CcSEcCtD
Paricalcitol—Alopecia—Epirubicin—ovarian cancer	0.000441	0.000677	CcSEcCtD
Paricalcitol—Pruritus—Paclitaxel—ovarian cancer	0.000438	0.000674	CcSEcCtD
Paricalcitol—Mental disorder—Epirubicin—ovarian cancer	0.000437	0.000671	CcSEcCtD
Paricalcitol—Malnutrition—Epirubicin—ovarian cancer	0.000434	0.000667	CcSEcCtD
Paricalcitol—Feeling abnormal—Docetaxel—ovarian cancer	0.000433	0.000665	CcSEcCtD
Paricalcitol—Eye disorder—Doxorubicin—ovarian cancer	0.000431	0.000663	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000429	0.00066	CcSEcCtD
Paricalcitol—Cardiac disorder—Doxorubicin—ovarian cancer	0.000428	0.000658	CcSEcCtD
Paricalcitol—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	0.000427	0.00208	CbGpPWpGaD
Paricalcitol—Tension—Epirubicin—ovarian cancer	0.000426	0.000655	CcSEcCtD
Paricalcitol—Dysgeusia—Epirubicin—ovarian cancer	0.000425	0.000653	CcSEcCtD
Paricalcitol—Diarrhoea—Paclitaxel—ovarian cancer	0.000424	0.000652	CcSEcCtD
Paricalcitol—Nervousness—Epirubicin—ovarian cancer	0.000422	0.000648	CcSEcCtD
Paricalcitol—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	0.000421	0.00206	CbGpPWpGaD
Paricalcitol—Back pain—Epirubicin—ovarian cancer	0.00042	0.000645	CcSEcCtD
Paricalcitol—Angiopathy—Doxorubicin—ovarian cancer	0.000419	0.000643	CcSEcCtD
Paricalcitol—Muscle spasms—Epirubicin—ovarian cancer	0.000417	0.000641	CcSEcCtD
Paricalcitol—Immune system disorder—Doxorubicin—ovarian cancer	0.000417	0.000641	CcSEcCtD
Paricalcitol—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000416	0.000639	CcSEcCtD
Paricalcitol—Abdominal pain—Docetaxel—ovarian cancer	0.000415	0.000638	CcSEcCtD
Paricalcitol—Body temperature increased—Docetaxel—ovarian cancer	0.000415	0.000638	CcSEcCtD
Paricalcitol—Chills—Doxorubicin—ovarian cancer	0.000414	0.000636	CcSEcCtD
Paricalcitol—Arrhythmia—Doxorubicin—ovarian cancer	0.000412	0.000634	CcSEcCtD
Paricalcitol—Dizziness—Paclitaxel—ovarian cancer	0.00041	0.00063	CcSEcCtD
Paricalcitol—Alopecia—Doxorubicin—ovarian cancer	0.000408	0.000627	CcSEcCtD
Paricalcitol—Mental disorder—Doxorubicin—ovarian cancer	0.000404	0.000621	CcSEcCtD
Paricalcitol—Ill-defined disorder—Epirubicin—ovarian cancer	0.000403	0.000619	CcSEcCtD
Paricalcitol—Malnutrition—Doxorubicin—ovarian cancer	0.000402	0.000617	CcSEcCtD
Paricalcitol—Anaemia—Epirubicin—ovarian cancer	0.000401	0.000617	CcSEcCtD
Paricalcitol—Agitation—Epirubicin—ovarian cancer	0.000399	0.000613	CcSEcCtD
Paricalcitol—Tension—Doxorubicin—ovarian cancer	0.000394	0.000606	CcSEcCtD
Paricalcitol—Vomiting—Paclitaxel—ovarian cancer	0.000394	0.000606	CcSEcCtD
Paricalcitol—Dysgeusia—Doxorubicin—ovarian cancer	0.000393	0.000605	CcSEcCtD
Paricalcitol—Malaise—Epirubicin—ovarian cancer	0.000391	0.000602	CcSEcCtD
Paricalcitol—Rash—Paclitaxel—ovarian cancer	0.000391	0.000601	CcSEcCtD
Paricalcitol—Dermatitis—Paclitaxel—ovarian cancer	0.00039	0.0006	CcSEcCtD
Paricalcitol—Nervousness—Doxorubicin—ovarian cancer	0.00039	0.0006	CcSEcCtD
Paricalcitol—Vertigo—Epirubicin—ovarian cancer	0.00039	0.000599	CcSEcCtD
Paricalcitol—Syncope—Epirubicin—ovarian cancer	0.000389	0.000598	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—BRIP1—ovarian cancer	0.000389	0.0019	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—PPP1CC—ovarian cancer	0.000389	0.0019	CbGpPWpGaD
Paricalcitol—Leukopenia—Epirubicin—ovarian cancer	0.000389	0.000597	CcSEcCtD
Paricalcitol—Back pain—Doxorubicin—ovarian cancer	0.000388	0.000597	CcSEcCtD
Paricalcitol—Headache—Paclitaxel—ovarian cancer	0.000388	0.000597	CcSEcCtD
Paricalcitol—Hypersensitivity—Docetaxel—ovarian cancer	0.000387	0.000595	CcSEcCtD
Paricalcitol—Muscle spasms—Doxorubicin—ovarian cancer	0.000386	0.000594	CcSEcCtD
Paricalcitol—Palpitations—Epirubicin—ovarian cancer	0.000384	0.00059	CcSEcCtD
Paricalcitol—Loss of consciousness—Epirubicin—ovarian cancer	0.000381	0.000586	CcSEcCtD
Paricalcitol—Cough—Epirubicin—ovarian cancer	0.000379	0.000582	CcSEcCtD
Paricalcitol—Asthenia—Docetaxel—ovarian cancer	0.000377	0.000579	CcSEcCtD
Paricalcitol—VDR—Direct p53 effectors—TP53—ovarian cancer	0.000376	0.00183	CbGpPWpGaD
Paricalcitol—Hypertension—Epirubicin—ovarian cancer	0.000375	0.000576	CcSEcCtD
Paricalcitol—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000373	0.000573	CcSEcCtD
Paricalcitol—Pruritus—Docetaxel—ovarian cancer	0.000372	0.000571	CcSEcCtD
Paricalcitol—Anaemia—Doxorubicin—ovarian cancer	0.000371	0.000571	CcSEcCtD
Paricalcitol—Arthralgia—Epirubicin—ovarian cancer	0.00037	0.000568	CcSEcCtD
Paricalcitol—Chest pain—Epirubicin—ovarian cancer	0.00037	0.000568	CcSEcCtD
Paricalcitol—Myalgia—Epirubicin—ovarian cancer	0.00037	0.000568	CcSEcCtD
Paricalcitol—Agitation—Doxorubicin—ovarian cancer	0.000369	0.000567	CcSEcCtD
Paricalcitol—Anxiety—Epirubicin—ovarian cancer	0.000368	0.000566	CcSEcCtD
Paricalcitol—Nausea—Paclitaxel—ovarian cancer	0.000368	0.000566	CcSEcCtD
Paricalcitol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000367	0.000564	CcSEcCtD
Paricalcitol—Discomfort—Epirubicin—ovarian cancer	0.000365	0.000561	CcSEcCtD
Paricalcitol—Malaise—Doxorubicin—ovarian cancer	0.000362	0.000557	CcSEcCtD
Paricalcitol—Dry mouth—Epirubicin—ovarian cancer	0.000361	0.000556	CcSEcCtD
Paricalcitol—Vertigo—Doxorubicin—ovarian cancer	0.000361	0.000555	CcSEcCtD
Paricalcitol—Syncope—Doxorubicin—ovarian cancer	0.00036	0.000554	CcSEcCtD
Paricalcitol—Leukopenia—Doxorubicin—ovarian cancer	0.000359	0.000553	CcSEcCtD
Paricalcitol—Diarrhoea—Docetaxel—ovarian cancer	0.000359	0.000552	CcSEcCtD
Paricalcitol—Confusional state—Epirubicin—ovarian cancer	0.000357	0.000549	CcSEcCtD
Paricalcitol—Palpitations—Doxorubicin—ovarian cancer	0.000355	0.000546	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	0.000355	0.00173	CbGpPWpGaD
Paricalcitol—Oedema—Epirubicin—ovarian cancer	0.000354	0.000545	CcSEcCtD
Paricalcitol—Loss of consciousness—Doxorubicin—ovarian cancer	0.000353	0.000543	CcSEcCtD
Paricalcitol—Infection—Epirubicin—ovarian cancer	0.000352	0.000541	CcSEcCtD
Paricalcitol—VDR—Gene Expression—YAP1—ovarian cancer	0.000352	0.00172	CbGpPWpGaD
Paricalcitol—Cough—Doxorubicin—ovarian cancer	0.00035	0.000539	CcSEcCtD
Paricalcitol—Shock—Epirubicin—ovarian cancer	0.000349	0.000536	CcSEcCtD
Paricalcitol—Nervous system disorder—Epirubicin—ovarian cancer	0.000347	0.000534	CcSEcCtD
Paricalcitol—Dizziness—Docetaxel—ovarian cancer	0.000347	0.000534	CcSEcCtD
Paricalcitol—Hypertension—Doxorubicin—ovarian cancer	0.000347	0.000533	CcSEcCtD
Paricalcitol—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.000346	0.00169	CbGpPWpGaD
Paricalcitol—Skin disorder—Epirubicin—ovarian cancer	0.000344	0.000529	CcSEcCtD
Paricalcitol—Hyperhidrosis—Epirubicin—ovarian cancer	0.000342	0.000526	CcSEcCtD
Paricalcitol—Myalgia—Doxorubicin—ovarian cancer	0.000342	0.000526	CcSEcCtD
Paricalcitol—Chest pain—Doxorubicin—ovarian cancer	0.000342	0.000526	CcSEcCtD
Paricalcitol—Arthralgia—Doxorubicin—ovarian cancer	0.000342	0.000526	CcSEcCtD
Paricalcitol—Anxiety—Doxorubicin—ovarian cancer	0.000341	0.000524	CcSEcCtD
Paricalcitol—VDR—Generic Transcription Pathway—ESR1—ovarian cancer	0.000341	0.00166	CbGpPWpGaD
Paricalcitol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.00034	0.000522	CcSEcCtD
Paricalcitol—Discomfort—Doxorubicin—ovarian cancer	0.000338	0.000519	CcSEcCtD
Paricalcitol—Anorexia—Epirubicin—ovarian cancer	0.000338	0.000519	CcSEcCtD
Paricalcitol—Dry mouth—Doxorubicin—ovarian cancer	0.000334	0.000514	CcSEcCtD
Paricalcitol—Vomiting—Docetaxel—ovarian cancer	0.000334	0.000513	CcSEcCtD
Paricalcitol—Rash—Docetaxel—ovarian cancer	0.000331	0.000509	CcSEcCtD
Paricalcitol—Hypotension—Epirubicin—ovarian cancer	0.000331	0.000509	CcSEcCtD
Paricalcitol—Dermatitis—Docetaxel—ovarian cancer	0.000331	0.000509	CcSEcCtD
Paricalcitol—Confusional state—Doxorubicin—ovarian cancer	0.00033	0.000508	CcSEcCtD
Paricalcitol—Headache—Docetaxel—ovarian cancer	0.000329	0.000506	CcSEcCtD
Paricalcitol—Oedema—Doxorubicin—ovarian cancer	0.000328	0.000504	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—YAP1—ovarian cancer	0.000326	0.00159	CbGpPWpGaD
Paricalcitol—Infection—Doxorubicin—ovarian cancer	0.000326	0.000501	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	0.000323	0.00158	CbGpPWpGaD
Paricalcitol—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000323	0.000496	CcSEcCtD
Paricalcitol—Shock—Doxorubicin—ovarian cancer	0.000322	0.000496	CcSEcCtD
Paricalcitol—Nervous system disorder—Doxorubicin—ovarian cancer	0.000321	0.000494	CcSEcCtD
Paricalcitol—Insomnia—Epirubicin—ovarian cancer	0.00032	0.000492	CcSEcCtD
Paricalcitol—Skin disorder—Doxorubicin—ovarian cancer	0.000318	0.000489	CcSEcCtD
Paricalcitol—Paraesthesia—Epirubicin—ovarian cancer	0.000318	0.000489	CcSEcCtD
Paricalcitol—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000317	0.000487	CcSEcCtD
Paricalcitol—Dyspnoea—Epirubicin—ovarian cancer	0.000316	0.000485	CcSEcCtD
Paricalcitol—Somnolence—Epirubicin—ovarian cancer	0.000315	0.000484	CcSEcCtD
Paricalcitol—Anorexia—Doxorubicin—ovarian cancer	0.000312	0.00048	CcSEcCtD
Paricalcitol—Nausea—Docetaxel—ovarian cancer	0.000312	0.00048	CcSEcCtD
Paricalcitol—Dyspepsia—Epirubicin—ovarian cancer	0.000312	0.000479	CcSEcCtD
Paricalcitol—Decreased appetite—Epirubicin—ovarian cancer	0.000308	0.000473	CcSEcCtD
Paricalcitol—VDR—Gene Expression—PGR—ovarian cancer	0.000307	0.0015	CbGpPWpGaD
Paricalcitol—Hypotension—Doxorubicin—ovarian cancer	0.000306	0.000471	CcSEcCtD
Paricalcitol—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000306	0.00047	CcSEcCtD
Paricalcitol—Fatigue—Epirubicin—ovarian cancer	0.000305	0.000469	CcSEcCtD
Paricalcitol—Constipation—Epirubicin—ovarian cancer	0.000303	0.000466	CcSEcCtD
Paricalcitol—Pain—Epirubicin—ovarian cancer	0.000303	0.000466	CcSEcCtD
Paricalcitol—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000299	0.000459	CcSEcCtD
Paricalcitol—Insomnia—Doxorubicin—ovarian cancer	0.000296	0.000456	CcSEcCtD
Paricalcitol—Paraesthesia—Doxorubicin—ovarian cancer	0.000294	0.000452	CcSEcCtD
Paricalcitol—Dyspnoea—Doxorubicin—ovarian cancer	0.000292	0.000449	CcSEcCtD
Paricalcitol—Feeling abnormal—Epirubicin—ovarian cancer	0.000292	0.000449	CcSEcCtD
Paricalcitol—Somnolence—Doxorubicin—ovarian cancer	0.000291	0.000448	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Epirubicin—ovarian cancer	0.00029	0.000445	CcSEcCtD
Paricalcitol—Dyspepsia—Doxorubicin—ovarian cancer	0.000289	0.000443	CcSEcCtD
Paricalcitol—VDR—Gene Expression—PARP1—ovarian cancer	0.000286	0.00139	CbGpPWpGaD
Paricalcitol—Decreased appetite—Doxorubicin—ovarian cancer	0.000285	0.000438	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	0.000284	0.00139	CbGpPWpGaD
Paricalcitol—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000283	0.000435	CcSEcCtD
Paricalcitol—Fatigue—Doxorubicin—ovarian cancer	0.000283	0.000434	CcSEcCtD
Paricalcitol—Urticaria—Epirubicin—ovarian cancer	0.000281	0.000433	CcSEcCtD
Paricalcitol—Constipation—Doxorubicin—ovarian cancer	0.00028	0.000431	CcSEcCtD
Paricalcitol—Pain—Doxorubicin—ovarian cancer	0.00028	0.000431	CcSEcCtD
Paricalcitol—Abdominal pain—Epirubicin—ovarian cancer	0.00028	0.00043	CcSEcCtD
Paricalcitol—Body temperature increased—Epirubicin—ovarian cancer	0.00028	0.00043	CcSEcCtD
Paricalcitol—Feeling abnormal—Doxorubicin—ovarian cancer	0.00027	0.000415	CcSEcCtD
Paricalcitol—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000268	0.000412	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—FASN—ovarian cancer	0.000266	0.0013	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—SLC5A5—ovarian cancer	0.000262	0.00128	CbGpPWpGaD
Paricalcitol—Hypersensitivity—Epirubicin—ovarian cancer	0.000261	0.000401	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—YAP1—ovarian cancer	0.000261	0.00127	CbGpPWpGaD
Paricalcitol—Urticaria—Doxorubicin—ovarian cancer	0.00026	0.0004	CcSEcCtD
Paricalcitol—Abdominal pain—Doxorubicin—ovarian cancer	0.000259	0.000398	CcSEcCtD
Paricalcitol—Body temperature increased—Doxorubicin—ovarian cancer	0.000259	0.000398	CcSEcCtD
Paricalcitol—Asthenia—Epirubicin—ovarian cancer	0.000254	0.000391	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—SLC2A1—ovarian cancer	0.000253	0.00123	CbGpPWpGaD
Paricalcitol—Pruritus—Epirubicin—ovarian cancer	0.000251	0.000385	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	0.000248	0.00121	CbGpPWpGaD
Paricalcitol—Diarrhoea—Epirubicin—ovarian cancer	0.000242	0.000373	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—CYP1B1—ovarian cancer	0.000242	0.00118	CbGpPWpGaD
Paricalcitol—Hypersensitivity—Doxorubicin—ovarian cancer	0.000241	0.000371	CcSEcCtD
Paricalcitol—Asthenia—Doxorubicin—ovarian cancer	0.000235	0.000361	CcSEcCtD
Paricalcitol—Dizziness—Epirubicin—ovarian cancer	0.000234	0.00036	CcSEcCtD
Paricalcitol—Pruritus—Doxorubicin—ovarian cancer	0.000232	0.000356	CcSEcCtD
Paricalcitol—VDR—Gene Expression—PPP2R1A—ovarian cancer	0.000232	0.00113	CbGpPWpGaD
Paricalcitol—Vomiting—Epirubicin—ovarian cancer	0.000225	0.000346	CcSEcCtD
Paricalcitol—Diarrhoea—Doxorubicin—ovarian cancer	0.000224	0.000345	CcSEcCtD
Paricalcitol—Rash—Epirubicin—ovarian cancer	0.000223	0.000343	CcSEcCtD
Paricalcitol—Dermatitis—Epirubicin—ovarian cancer	0.000223	0.000343	CcSEcCtD
Paricalcitol—Headache—Epirubicin—ovarian cancer	0.000222	0.000341	CcSEcCtD
Paricalcitol—Dizziness—Doxorubicin—ovarian cancer	0.000217	0.000333	CcSEcCtD
Paricalcitol—CYP24A1—Metabolism—PPP2R1A—ovarian cancer	0.000215	0.00105	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	0.000214	0.00104	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—FASN—ovarian cancer	0.000213	0.00104	CbGpPWpGaD
Paricalcitol—Nausea—Epirubicin—ovarian cancer	0.00021	0.000323	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—SLC5A5—ovarian cancer	0.000209	0.00102	CbGpPWpGaD
Paricalcitol—Vomiting—Doxorubicin—ovarian cancer	0.000208	0.00032	CcSEcCtD
Paricalcitol—Rash—Doxorubicin—ovarian cancer	0.000207	0.000318	CcSEcCtD
Paricalcitol—Dermatitis—Doxorubicin—ovarian cancer	0.000206	0.000317	CcSEcCtD
Paricalcitol—Headache—Doxorubicin—ovarian cancer	0.000205	0.000316	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—SLC2A1—ovarian cancer	0.000202	0.000986	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—ABCB1—ovarian cancer	0.0002	0.000973	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—TYMS—ovarian cancer	0.000196	0.000956	CbGpPWpGaD
Paricalcitol—Nausea—Doxorubicin—ovarian cancer	0.000195	0.000299	CcSEcCtD
Paricalcitol—UGT1A4—Metabolism—CYP1B1—ovarian cancer	0.000194	0.000945	CbGpPWpGaD
Paricalcitol—CYP3A4—Biological oxidations—CYP1B1—ovarian cancer	0.000184	0.000897	CbGpPWpGaD
Paricalcitol—CYP3A4—Metapathway biotransformation—CYP1B1—ovarian cancer	0.000181	0.000885	CbGpPWpGaD
Paricalcitol—VDR—Generic Transcription Pathway—MYC—ovarian cancer	0.000177	0.000864	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—PPP2R1A—ovarian cancer	0.000172	0.000838	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—ESR1—ovarian cancer	0.000164	0.0008	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—ABCB1—ovarian cancer	0.00016	0.000778	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—CAV1—ovarian cancer	0.000158	0.00077	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—TYMS—ovarian cancer	0.000157	0.000764	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	0.000151	0.000736	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—PIK3CG—ovarian cancer	0.000144	0.000702	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—PIK3CD—ovarian cancer	0.000126	0.000617	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—CAV1—ovarian cancer	0.000126	0.000616	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—PIK3CG—ovarian cancer	0.000115	0.000561	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—NME2—ovarian cancer	0.000112	0.000547	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—PIK3CB—ovarian cancer	0.00011	0.000538	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—PIK3CD—ovarian cancer	0.000101	0.000493	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—PTEN—ovarian cancer	9.53e-05	0.000465	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—PIK3CB—ovarian cancer	8.81e-05	0.00043	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—MAPK3—ovarian cancer	8.77e-05	0.000428	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—MYC—ovarian cancer	8.53e-05	0.000416	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—PTEN—ovarian cancer	7.62e-05	0.000371	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CYTB—ovarian cancer	7.23e-05	0.000352	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—PIK3CA—ovarian cancer	6.72e-05	0.000328	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PPP1CC—ovarian cancer	6.32e-05	0.000308	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—BRIP1—ovarian cancer	6.32e-05	0.000308	CbGpPWpGaD
Paricalcitol—VDR—Gene Expression—AKT1—ovarian cancer	5.92e-05	0.000289	CbGpPWpGaD
Paricalcitol—CYP24A1—Metabolism—AKT1—ovarian cancer	5.49e-05	0.000268	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—PIK3CA—ovarian cancer	5.37e-05	0.000262	CbGpPWpGaD
Paricalcitol—UGT1A4—Metabolism—AKT1—ovarian cancer	4.39e-05	0.000214	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—YAP1—ovarian cancer	4.24e-05	0.000207	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—FASN—ovarian cancer	3.45e-05	0.000168	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—SLC5A5—ovarian cancer	3.4e-05	0.000166	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—SLC2A1—ovarian cancer	3.28e-05	0.00016	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CYP1B1—ovarian cancer	3.15e-05	0.000153	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	2.79e-05	0.000136	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—ABCB1—ovarian cancer	2.59e-05	0.000126	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—TYMS—ovarian cancer	2.54e-05	0.000124	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—CAV1—ovarian cancer	2.05e-05	0.0001	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PIK3CG—ovarian cancer	1.87e-05	9.11e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PIK3CD—ovarian cancer	1.64e-05	8.01e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PIK3CB—ovarian cancer	1.43e-05	6.98e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PTEN—ovarian cancer	1.24e-05	6.03e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—PIK3CA—ovarian cancer	8.72e-06	4.25e-05	CbGpPWpGaD
Paricalcitol—CYP3A4—Metabolism—AKT1—ovarian cancer	7.12e-06	3.47e-05	CbGpPWpGaD
